| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,993 |
10,541 |
$2.08M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,438 |
3,706 |
$565K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,615 |
1,248 |
$378K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
968 |
596 |
$342K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,285 |
3,701 |
$304K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,961 |
3,260 |
$130K |
| 80053 |
Comprehensive metabolic panel |
13,834 |
10,862 |
$110K |
| 85027 |
|
14,174 |
10,820 |
$68K |
| 86710 |
|
3,065 |
2,467 |
$53K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,553 |
2,910 |
$48K |
| 36415 |
Collection of venous blood by venipuncture |
16,852 |
12,970 |
$37K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
292 |
95 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,574 |
3,440 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
521 |
382 |
$22K |
| 80061 |
Lipid panel |
2,065 |
1,706 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
598 |
454 |
$19K |
| 87430 |
|
1,572 |
1,268 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
681 |
549 |
$18K |
| 93000 |
|
279 |
201 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
253 |
224 |
$13K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
482 |
96 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,204 |
834 |
$10K |
| 81001 |
|
3,607 |
2,623 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
17 |
13 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,120 |
825 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
39 |
34 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
477 |
384 |
$3K |
| 0001A |
|
119 |
66 |
$3K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
65 |
12 |
$2K |
| 81015 |
|
734 |
632 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
429 |
305 |
$2K |
| 83735 |
|
473 |
296 |
$2K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
88 |
62 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
77 |
55 |
$1K |
| 85730 |
|
272 |
190 |
$908.67 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
31 |
26 |
$851.66 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
140 |
93 |
$780.06 |
| 84703 |
|
92 |
76 |
$705.94 |
| 84484 |
|
143 |
83 |
$648.44 |
| 85610 |
|
269 |
188 |
$631.21 |
| J3490 |
Unclassified drugs |
104 |
72 |
$513.80 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$476.56 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$476.56 |
| 83690 |
|
109 |
80 |
$467.29 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32 |
26 |
$424.32 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
63 |
38 |
$379.68 |
| 87807 |
|
39 |
31 |
$353.70 |
| J7050 |
Infusion, normal saline solution, 250 cc |
432 |
117 |
$338.63 |
| 82150 |
|
90 |
66 |
$317.52 |
| 85379 |
|
37 |
18 |
$193.42 |
| 86803 |
|
19 |
16 |
$171.24 |
| 86140 |
|
63 |
37 |
$168.56 |
| 85651 |
|
49 |
42 |
$162.26 |
| 83525 |
|
12 |
12 |
$137.16 |
| 80076 |
|
13 |
12 |
$73.53 |
| 81003 |
|
27 |
19 |
$42.23 |
| T1015 |
Clinic visit/encounter, all-inclusive |
70 |
51 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
93 |
62 |
$0.00 |
| 91300 |
|
70 |
65 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
44 |
13 |
$0.00 |